Hait Bio: The net loss for the first quarter of 2026 was 23.0463 million yuan.

Haite Biology announced that its revenue in the first quarter of 2026 was 159 million yuan, an increase of 1.52% year-on-year; the net loss was 23.04 million yuan, compared to a net loss of 13.93 million yuan in the same period last year.